HAEMONETICS CORP·4

May 2, 7:18 PM ET

ALLEN PETER M 4

4 · HAEMONETICS CORP · Filed May 2, 2013

Insider Transaction Report

Form 4
Period: 2013-04-30
ALLEN PETER M
Chief Marketing Officer
Transactions
  • Purchase

    Common Stock

    2013-04-30$32.73/sh+451$14,75926,797 total
Holdings
  • Non-Qualified Stock Option (right to buy)

    Exercise: $26.47From: 2010-10-27Exp: 2016-10-27Common Stock (31,340 underlying)
    31,340
  • Non-Qualified Stock Option (right to buy)

    Exercise: $27.50From: 2011-10-27Exp: 2017-10-27Common Stock (30,776 underlying)
    30,776
  • Non-Qualified Stock Option (right to buy)

    Exercise: $30.67From: 2012-10-25Exp: 2018-10-25Common Stock (30,740 underlying)
    30,740
  • Non-Qualified Stock Option (right to buy)

    Exercise: $13.05From: 2005-05-05Exp: 2014-05-05Common Stock (30,000 underlying)
    30,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $25.54From: 2008-10-24Exp: 2014-10-24Common Stock (36,426 underlying)
    36,426
  • Non-Qualified Stock Option (right to buy)

    Exercise: $27.27From: 2009-10-22Exp: 2015-10-22Common Stock (30,494 underlying)
    30,494
  • Non-Qualified Stock Option (right to buy)

    Exercise: $39.05From: 2013-10-24Exp: 2019-10-24Common Stock (32,192 underlying)
    32,192
Footnotes (3)
  • [F1]Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction.
  • [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
  • [F3]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT